Ebv-positive Diffuse Large B-cell Lymphoma Not Otherwise Specified
📧 Sign up to get email alerts when something new happens for Ebv-positive Diffuse Large B-cell Lymphoma Not Otherwise Specified.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas [Phase 2]
Phase 2 trial evaluating nivolumab with or without varlilumab in relapsed or refractory aggressive B-cell lymphomas, including multiple DLBC…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS [Phase 2]
Phase 2 trial evaluating Sintilimab plus R-CHOP in treatment-naive EBV-positive DLBCL, NOS.